Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!
Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Latest Articles
- Longhorn Exploration (LEX.V) rockets 192% a week after hydrogen project news
- Saga Metals Corp (SAGA.V): Set to go public as Rio Tinto JV drops
- BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies begin
- Top 5 Stock Market Gainers and Losers: MCF.V, BRMI.TO, NKE.NE
- Gold to trigger reversal pattern down to $2100?
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion California Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V FIRE Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading wealth wealth creation weed
Leave a Reply